Therapeutic potential of TGF-β inhibition in chronic renal failure

被引：36
作者：
Gagliardini, Elena [1 ]
Benigni, Ariela [1 ]
机构：
[1] Mario Negri Inst Pharmaceut Res, I-24125 Bergamo, Italy
来源：
EXPERT OPINION ON BIOLOGICAL THERAPY | 2007年 / 7卷 / 03期
关键词：
progressive nephropathies; proteinuria; renal fibrosis; transforming growth factor-beta;
D O I：
10.1517/14712598.7.3.293
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Chronic kidney diseases are emerging as a worldwide public health problem. The progression of kidney diseases closely correlates with the accumulation of extracellular matrix leading to glomerulosclerosis and tubulointerstitial injury. Transforming growth factor (TGF)-beta has been identified as a key mediator of kidney matrix accumulation. Overexpression of TGF-beta isoforms and their receptors was observed in a variety of renal diseases in both animals and humans. Given its crucial role in fibrotic kidney disease, TGF-beta has been recently considered as a possible target in the management of chronic renal diseases. This review discusses the role of TGF-beta in renal fibrosis and provides an overview of the strategies that, when interfering with TGF-beta expression and signalling, could be employed as new renoprotective treatments.
引用
收藏
页码：293 / 304
页数：12
相关论文
共 130 条
[1]   Transforming growth factor-β1 is up-regulated by podocytes in response to excess intraglomerular passage of proteins -: A central pathway in progressive glomerulosclerosis [J].
Abbate, M ;
Zoja, C ;
Morigi, M ;
Rottoli, D ;
Angioletti, S ;
Tomasoni, S ;
Zanchi, C ;
Longaretti, L ;
Donadelli, R ;
Remuzzi, G .
AMERICAN JOURNAL OF PATHOLOGY, 2002, 161 (06) :2179-2193
[2]   Proximal tubular cells promote fibrogenesis by TGF-β1-mediated induction of peritubular myofibroblasts [J].
Abbate, M ;
Zoja, C ;
Rottoli, D ;
Corna, D ;
Tomasoni, S ;
Remuzzi, G .
KIDNEY INTERNATIONAL, 2002, 61 (06) :2066-2077
[3]   Inhibition of TGF-beta 1 expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis [J].
Akagi, Y ;
Isaka, Y ;
Arai, M ;
Kaneko, T ;
Takenaka, M ;
Moriyama, T ;
Kaneda, Y ;
Ando, A ;
Orita, Y ;
Kamada, T ;
Ueda, N ;
Imai, E .
KIDNEY INTERNATIONAL, 1996, 50 (01) :148-155
[4]   Localization of TGF-β and its receptors in the kidney [J].
Ando, T ;
Okuda, S ;
Yanagida, T ;
Fujishima, M .
MINERAL AND ELECTROLYTE METABOLISM, 1998, 24 (2-3) :149-153
[5]   Urinary transforming growth factor-β1 in feline chronic renal failure [J].
Arata, S ;
Ohmi, A ;
Mizukoshi, F ;
Baba, K ;
Ohno, K ;
Setoguchi, A ;
Tsujimoto, H .
JOURNAL OF VETERINARY MEDICAL SCIENCE, 2005, 67 (12) :1253-1255
[6]   PHARMACOLOGICAL PROPERTIES OF N-(3',4'-DIMETHOXYCINNAMOYL) ANTHRANILIC ACID (N-5'), A NEW ANTI-ATOPIC AGENT [J].
AZUMA, H ;
BANNO, K ;
YOSHIMURA, T .
BRITISH JOURNAL OF PHARMACOLOGY, 1976, 58 (04) :483-488
[7]   Add-on anti-TGF-β antibody to ACE inhibitor arrests progressive diabetic nephropathy in the rat [J].
Benigni, A ;
Zoja, C ;
Corna, D ;
Zatelli, C ;
Conti, S ;
Campana, M ;
Gagliardini, E ;
Rottoli, D ;
Zanchi, C ;
Abbate, M ;
Ledbetter, S ;
Remuzzi, G .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (07) :1816-1824
[8]   Beneficial effect of TGFβ antagonism in treating diabetic nephropathy depends on when treatment is started [J].
Benigni, Ariela ;
Zoja, Carla ;
Campana, Marco ;
Corna, Daniela ;
Sangalli, Fabio ;
Rottoli, Daniela ;
Gagliardini, Elena ;
Conti, Sara ;
Ledbetter, Steve ;
Remuzzi, Giuseppe .
NEPHRON EXPERIMENTAL NEPHROLOGY, 2006, 104 (04) :E158-e168
[9]   TUBULOINTERSTITIAL LESIONS MEDIATE RENAL DAMAGE IN ADRIAMYCIN GLOMERULOPATHY [J].
BERTANI, T ;
CUTILLO, F ;
ZOJA, C ;
BROGGINI, M ;
REMUZZI, G .
KIDNEY INTERNATIONAL, 1986, 30 (04) :488-496
[10]   Mechanisms of disease:: Role of transforming growth factor β in human disease. [J].
Blobe, GC ;
Schiemann, WP ;
Lodish, HF .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (18) :1350-1358
12345678910